Form 4 for HCAT Health Catalyst, Inc.
Accepted 2022-04-14 00:00:00 ET · period of report 2022-04-12 · accession 0001562180-22-003409 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-14 | 2022-04-12 | HCAT | Horstmeier Paul | COO | M - OptEx | $15.34 | +5,208 | 185.5K | +3% | +$79.9K |
| D | 2022-04-14 | 2022-04-12 | HCAT | Horstmeier Paul | COO | S - Sale+OE | $25.16 | -5,208 | 180.3K | -3% | -$131.0K |
| DM | 2022-04-14 | 2022-04-12 | HCAT | Horstmeier Paul | COO | M - OptEx | $0.00 | -5,208 | 18.5K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-12 | M | A | 520 | $15.84 | 180,836 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-12 | M | A | 4,167 | $15.84 | 185,003 | D | — | — | |
| 3 | Common | Common Stock | 2022-04-12 | M | A | 521 | $10.80 | 185,524 | D | — | — | |
| 4 | Common | Common Stock | 2022-04-12 | S | D | 5,208 | $25.16 | 180,316 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-04-12 | M | D | 4,167 | $0.00 | 35,402 | D | $15.84 · — to 2029-02-05 | 4,167 Common Stock | (F2) 25% of the 186,467 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-04-12 | M | D | 520 | $0.00 | 5,728 | D | $15.84 · — to 2029-02-05 | 520 Common Stock | (F3) 25% of the 25,000 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023. |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-04-12 | M | D | 521 | $0.00 | 18,474 | D | $10.80 · — to 2028-09-27 | 521 Common Stock | (F4) 25% of the 18,995 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. |